MARKET

RNA

RNA

Avidity Biosciences, Inc.
NASDAQ
6.16
-0.10
-1.60%
Closed 16:02 11/27 EST
OPEN
6.19
PREV CLOSE
6.26
HIGH
6.25
LOW
5.97
VOLUME
650.17K
TURNOVER
0
52 WEEK HIGH
25.74
52 WEEK LOW
4.825
MARKET CAP
456.46M
P/E (TTM)
-2.0608
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at RNA last week (1120-1124)?
Weekly Report · 23h ago
Weekly Report: what happened at RNA last week (1113-1117)?
Weekly Report · 11/20 10:48
Analysts Are Bullish on Top Healthcare Stocks: Avidity Biosciences (RNA), Xeris Pharmaceuticals (XERS)
TipRanks · 11/14 08:11
Weekly Report: what happened at RNA last week (1106-1110)?
Weekly Report · 11/13 10:42
Avidity Biosciences: Promising Clinical Outcomes and Strong Financial Health Bolster Buy Recommendation
TipRanks · 11/09 18:31
Avidity Biosciences, Inc.: Quarterly report
Press release · 11/09 01:58
Analysts Conflicted on These Healthcare Names: Stryker (SYK) and Avidity Biosciences (RNA)
TipRanks · 11/08 23:50
Avidity Biosciences GAAP EPS of -$0.71 beats by $0.05, revenue of $2.8M beats by $0.96M
Avidity biosciences q3 gaap eps of -$0.71 beats by $0.05, revenue of $2.8m (+12.9% y/y) beats. Ended the third quarter of 2023 with cash, cash equivalents and marketable securities totaling $542.6 million.
Seeking Alpha · 11/08 22:48
More
About RNA
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs.). The Company's AOC platform is designed to combine the specificity of monoclonal antibodies (mAbs), with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with RNA therapeutics. The AOC platform also has the option to deploy various types of oligonucleotides, including small interfering RNA (siRNAs) and patient measure of safety (PMOs), whose specific mechanisms of action modify RNA function in different ways. The Company's pipeline includes AOC 1001, and AOC 1020. AOC 1001 is designed to treat people with myotonic dystrophy type 1 (DM1). AOC 1020 is designed to treat people living with facioscapulohumeral.

Webull offers Avidity Biosciences Inc stock information, including NASDAQ: RNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNA stock methods without spending real money on the virtual paper trading platform.